These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 19652480

  • 1. Evaluation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations in dogs with mitral valve insufficiency.
    Takemura N, Toda N, Miyagawa Y, Asano K, Tejima K, Kanno N, Arisawa K, Kurita T, Nunokawa K, Hirakawa A, Tanaka S, Hirose H.
    J Vet Med Sci; 2009 Jul; 71(7):925-9. PubMed ID: 19652480
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission.
    Serres F, Pouchelon JL, Poujol L, Lefebvre HP, Trumel C, Daste T, Sampedrano CC, Gouni V, Tissier R, Hawa G, Chetboul V.
    J Vet Cardiol; 2009 Dec; 11(2):103-21. PubMed ID: 19850546
    [Abstract] [Full Text] [Related]

  • 5. Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.
    Fox PR, Oyama MA, Hezzell MJ, Rush JE, Nguyenba TP, DeFrancesco TC, Lehmkuhl LB, Kellihan HB, Bulmer B, Gordon SG, Cunningham SM, MacGregor J, Stepien RL, Lefbom B, Adin D, Lamb K.
    J Vet Intern Med; 2015 Jan; 29(1):171-9. PubMed ID: 25308881
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease.
    Wolf J, Gerlach N, Weber K, Klima A, Wess G.
    J Vet Cardiol; 2012 Sep; 14(3):399-408. PubMed ID: 22858663
    [Abstract] [Full Text] [Related]

  • 8. Effect of prespecified therapy escalation on plasma NT-proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease.
    Hezzell MJ, Block CL, Laughlin DS, Oyama MA.
    J Vet Intern Med; 2018 Sep; 32(5):1509-1516. PubMed ID: 30216549
    [Abstract] [Full Text] [Related]

  • 9. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease.
    Ogawa M, Hori Y, Kanno N, Iwasa N, Toyofuku T, Isayama N, Yoshikawa A, Akabane R, Sakatani A, Miyakawa H, Hsu HH, Miyagawa Y, Takemura N.
    J Vet Med Sci; 2021 Apr 24; 83(4):705-715. PubMed ID: 33551383
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease.
    Ettinger SJ, Farace G, Forney SD, Frye M, Beardow A.
    J Am Vet Med Assoc; 2012 Jan 15; 240(2):171-80. PubMed ID: 22217025
    [Abstract] [Full Text] [Related]

  • 11. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
    Wolf J, Gerlach N, Weber K, Klima A, Wess G.
    Vet Clin Pathol; 2013 Jun 15; 42(2):196-206. PubMed ID: 23614733
    [Abstract] [Full Text] [Related]

  • 12. Plasma humanin as a prognostic biomarker for canine myxomatous mitral valve disease: a comparison with plasma NT-roBNP.
    Mangkhang K, Punyapornwithaya V, Tankaew P, Pongkan W, Chattipakorn N, Boonyapakorn C.
    Pol J Vet Sci; 2018 Dec 15; 21(4):673-680. PubMed ID: 30605282
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic changes of plasma N-terminal pro-brain natriuretic peptide concentrations in 9 dogs with patent ductus arteriosus.
    Aramaki Y, Chimura S, Hori Y, Eguchi T.
    J Vet Med Sci; 2011 Jan 15; 73(1):83-8. PubMed ID: 20823663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relationship between glomerular filtration rate and plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with chronic kidney disease.
    Miyagawa Y, Tominaga Y, Toda N, Takemura N.
    Vet J; 2013 Aug 15; 197(2):445-50. PubMed ID: 23570775
    [Abstract] [Full Text] [Related]

  • 17. Plasma N-terminal pro-B-type natriuretic peptide concentration in healthy retired racing Greyhounds.
    Couto KM, Iazbik MC, Marín LM, Zaldivar-López S, Beal MJ, Gómez Ochoa P, Couto CG.
    Vet Clin Pathol; 2015 Sep 15; 44(3):405-9. PubMed ID: 25982692
    [Abstract] [Full Text] [Related]

  • 18. Utility of N-terminal pro-brain natriuretic peptide for assessing hemodynamic significance of patent ductus arteriosus in dogs undergoing ductal repair.
    Hariu CD, Saunders AB, Gordon SG, Norby B, Miller MW.
    J Vet Cardiol; 2013 Sep 15; 15(3):197-204. PubMed ID: 23933478
    [Abstract] [Full Text] [Related]

  • 19. N-Terminal Pro-B-Type Natriuretic Peptide and Phonocardiography in Differentiating Innocent Cardiac Murmurs from Congenital Cardiac Anomalies in Asymptomatic Puppies.
    Marinus SM, van Engelen H, Szatmári V.
    J Vet Intern Med; 2017 May 15; 31(3):661-667. PubMed ID: 28316101
    [Abstract] [Full Text] [Related]

  • 20. Correlation between NT-proBNP and lipase levels according to the severity of chronic mitral valve disease in dogs.
    Park JS, Park JH, Seo KW, Song KH.
    J Vet Sci; 2019 Jul 15; 20(4):e43. PubMed ID: 31364327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.